NYLI Candriam US Mid Cap Equity ETF Vs. Corcept Therapeutics, Inc. Industry Stock Comparison

Sell

44

IQSM
NYLI Candriam US Mid Cap Equity ETF

Last Price:

$34.96

Seasonality Move:

1.31%

Sell

30

CORT
Corcept Therapeutics, Inc.

Last Price:

$34.79

Seasonality Move:

13.21%

Sell

44

NYLI Candriam US Mid Cap Equity ETF (IQSM) is a Sell

Is NYLI Candriam US Mid Cap Equity ETF a Buy, Sell or Hold?

The current NYLI Candriam US Mid Cap Equity ETF [IQSM] share price is $34.62. The Score for IQSM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
IQSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

30

Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?

The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IQSM Stock Price Chart

What is NYLI Candriam US Mid Cap Equity ETF's stock price today?

The NYLI Candriam US Mid Cap Equity ETF share price today is $34.62

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IQSM is experiencing selling pressure, which indicates risk of future bearish movement.

CORT Stock Price Chart

What is Corcept Therapeutics, Inc.'s stock price today?

The Corcept Therapeutics, Inc. share price today is $34.80

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.

IQSM Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.22	Buy
Relative Strength Index (14 RSI):	47.61	Sell
Chaikin Money Flow:	-1497	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(34.43 - 35.15)	Sell
Bollinger Bands (100):	(33.46 - 34.7)	Buy

CORT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.88	Sell
Relative Strength Index (14 RSI):	14.83	Sell
Chaikin Money Flow:	-8077532	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(70.63 - 90.59)	Sell
Bollinger Bands (100):	(69.66 - 84.14)	Sell

IQSM Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	35.06	Sell
20-day SMA:	34.9	Sell
50-day SMA:	34.31	Buy
200-day SMA:	32.7	Buy
8-day EMA:	34.97	Sell
20-day EMA:	34.83	Sell
50-day EMA:	34.45	Buy
200-day EMA:	33.34	Buy

CORT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	75.24	Sell
20-day SMA:	80.76	Sell
50-day SMA:	77.62	Sell
200-day SMA:	73.92	Sell
8-day EMA:	69.79	Sell
20-day EMA:	76.79	Sell
50-day EMA:	77.19	Sell
200-day EMA:	51.2	Sell

NYLI Candriam US Mid Cap Equity ETF Earnings Growth & IQSM Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.

NYLI Candriam US Mid Cap Equity ETF Technical Analysis

	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31
	Dec
	16	17	18	19	22	24	26	29	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics, Inc. Technical Analysis

	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31
	Dec
	17	18	19	22	23	24	26	29	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):